Background: Diffuse large B cell lymphoma (DLBC L) is the most common subtype of non -Hodgkin lymphoma, a clinically and molecularly diverse g roup of cancers. DLBC L is difficult to diagnose and treat because of its fast development and the tendency for extranodal involvement. Aim: The primary aim of this study is to add to the expanding landscape of DLBC L research by determining the prevalence of GCB and non-GCB subg roups in the investigated patient population. Study Design: This is a prospective design study. Duration and Place of the Study: Th is study was conducted at the Department of Oncology, Hayatabad Medical Complex, Peshawar between 10th October 2022 and 10th September 2023. Material and Methods: There were a total of 100 patients. To classify patients into germinal center B cell (GCB) and non-GCB subty pes, diagnostic samples were exposed to a variety of immune-h istochemical testing, including markers such as C D10, Bcl-6, and MUM1. Results: Th is study involved 100 patients with DLBC L, with an average age of 58.4±12.6 years. 60% were male 40% were female, and 25% had B sy mptoms such as fever, night sweats, and weight loss. 70% of patients exhibited extranodal involvement, suggesting that the disease had gone beyond the lymph nodes. A considerable majority of patients had previously had treatment, w ith 40% receiv ing chemotherapy and 15% receiving radiation. Conclusion: The present study offers a detailed examination of the demog raphic and clinical att ributes of patients diagnosed with DLBC L, together w ith an analysis of the distribution of DLBC L subtypes and their correlation with clinical factors.